{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:10:33Z","timestamp":1792188633791,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01RX002334"],"award-info":[{"award-number":["I01RX002334"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Roskamp Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Repeated exposure to mild TBI (mTBI) has been linked to an increased risk of Alzheimer\u2019s disease (AD), chronic traumatic encephalopathy (CTE) and other neurodegenerative diseases. Some pathological features typically observed in AD have been found in postmortem brains of TBI and CTE, hence treatments tested for AD have a potential to be effective against r-mTBI outcomes. Neuroinflammation may present a possible answer due to its central role both in acute brain injury and in chronic degenerative-like disorders. Our previous studies have shown that drug nilvadipine, acting as an inhibitor of spleen tyrosine kinase (SYK), is effective at reducing inflammation, tau hyperphosphorylation and amyloid production in AD mouse models. To demonstrate the effect of nilvadipine in the absence of age-related variables, we introduced the same treatment to young r-mTBI mice. We further investigate therapeutic mechanisms of nilvadipine using its racemic properties. Both enantiomers, (+)-nilvadipine and (\u2212)-nilvadipine, can lower SYK activity, whereas (+)-nilvadipine is also a potent L-type calcium channel blocker (CCB) and shown to be anti-hypertensive. All r-mTBI mice exhibited increased neuroinflammation and impaired cognitive performance and motor functions. Treatment with racemic nilvadipine mitigated the TBI-induced inflammatory response and significantly improved spatial memory, whereas (\u2212)-enantiomer decreased microgliosis and improved spatial memory but failed to reduce the astroglial response to as much as the racemate. These results suggest the therapeutic potential of SYK inhibition that is enhanced when combined with the CCB effect, which indicate a therapeutic advantage of multi-action drugs for r-mTBI.<\/jats:p>","DOI":"10.1186\/s40478-020-01045-x","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T13:04:25Z","timestamp":1603112665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Nilvadipine suppresses inflammation via inhibition of P-SYK and restores spatial memory deficits in a mouse model of repetitive mild TBI"],"prefix":"10.1186","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2895-985X","authenticated-orcid":false,"given":"Alexander","family":"Morin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Mouzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Paris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie","family":"Browning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Mullan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"1045_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fneur.2020.00149","volume":"11","author":"L Abdullah","year":"2020","unstructured":"Abdullah L, Crawford F, Tsolaki M, B\u00f6rjesson-Hanson A, Olde Rikkert M, Pasquier F et al (2020) The influence of baseline Alzheimer\u2019s disease severity on cognitive decline and CSF biomarkers in the NILVAD trial. Front Neurol 11:149","journal-title":"Front Neurol"},{"issue":"2\u20133","key":"1045_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ejphar.2011.03.048","volume":"659","author":"C Bachmeier","year":"2011","unstructured":"Bachmeier C, Beaulieu-Abdelahad D, Mullan M, Paris D (2011) Selective dihydropyiridine compounds facilitate the clearance of $$ \\beta $$-amyloid across the blood\u2013brain barrier. Eur J Pharmacol 659(2\u20133):124\u20139","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1045_CR3","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2165\/00002512-199506020-00007","volume":"6","author":"RN Brogden","year":"1995","unstructured":"Brogden RN, McTavish D (1995) Nilvadipine: a review of its pharmacodynamic and pharmacokinetic properties, therapeutic use in hypertension and potential in cerebrovascular disease and angina. Drugs Aging 6(2):150\u201371","journal-title":"Drugs Aging"},{"issue":"Pt\u2013B","key":"1045_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.mcn.2015.03.007","volume":"66","author":"DH Daneshvar","year":"2015","unstructured":"Daneshvar DH, Goldstein LE, Kiernan PT, Stein TD, McKee AC (2015) Post-traumatic neurodegeneration and chronic traumatic encephalopathy. Mol Cell Neurosci 66(Pt\u2013B):81\u201390","journal-title":"Mol Cell Neurosci"},{"issue":"4","key":"1045_CR5","first-page":"1039","volume":"130","author":"MC Dewan","year":"2018","unstructured":"Dewan MC, Rattani A, Gupta S, Baticulon RE, Hung YC, Punchak M et al (2018) Estimating the global incidence of traumatic brain injury. J Neurosurg 130(4):1039\u20131408","journal-title":"J Neurosurg"},{"issue":"Pt\u2013B","key":"1045_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mcn.2015.03.001","volume":"66","author":"RC Gardner","year":"2015","unstructured":"Gardner RC, Yaffe K (2015) Epidemiology of mild traumatic brain injury and neurodegenerative disease. Mol Cell Neurosci 66(Pt\u2013B):75\u201380","journal-title":"Mol Cell Neurosci"},{"issue":"5","key":"1045_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11910-015-0545-1","volume":"15","author":"RM Guerriero","year":"2015","unstructured":"Guerriero RM, Giza CC, Rotenberg A (2015) Glutamate and GABA imbalance following traumatic brain injury. Curr Neurol Neurosci Rep 15(5):27","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"12","key":"1045_CR8","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/gps.1851","volume":"22","author":"H Hanyu","year":"2007","unstructured":"Hanyu H, Hirao K, Shimizu S, Sato T, Kiuchi A, Iwamoto T (2007) Nilvadipine prevents cognitive decline of patients with mild cognitive impairment. Int J Geriatr Psychiatry 22(12):1264\u20136","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2","key":"1045_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1055\/s-2000-9826","volume":"20","author":"BD Jordan","year":"2000","unstructured":"Jordan BD (2000) Chronic traumatic brain injury associated with boxing. Semin Neurol 20(2):179\u2013185","journal-title":"Semin Neurol"},{"issue":"10","key":"1045_CR10","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/gps.2638","volume":"26","author":"SP Kennelly","year":"2011","unstructured":"Kennelly SP, Abdullah L, Paris D, Parish J, Mathura V, Mullan M et al (2011) Demonstration of safety in Alzheimer\u2019s patients for intervention with an anti-hypertensive drug nilvadipine: results from a 6-week open label study. Int J Geriatr Psychiatry 26(10):1038\u201345","journal-title":"Int J Geriatr Psychiatry"},{"issue":"9","key":"1045_CR11","doi-asserted-by":"publisher","first-page":"e1002660","DOI":"10.1371\/journal.pmed.1002660","volume":"15","author":"B Lawlor","year":"2018","unstructured":"Lawlor B, Segurado R, Kennelly S, Olde Rikkert MGM, Howard R, Pasquier F et al (2018) Nilvadipine in mild to moderate Alzheimer disease: a randomised controlled trial. PLoS Med 15(9):e1002660","journal-title":"PLoS Med"},{"key":"1045_CR12","doi-asserted-by":"publisher","first-page":"e62422","DOI":"10.1371\/journal.pone.0062422","volume":"8","author":"Y-K Lee","year":"2013","unstructured":"Lee Y-K, Hou S-W, Lee C-C, Hsu C-Y, Huang Y-S, Su Y-C (2013) Increased risk of dementia in patients with mild traumatic brain injury: a nationwide cohort study. PLoS ONE 8:e62422","journal-title":"PLoS ONE"},{"key":"1045_CR13","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1056\/NEJMoa1908483","volume":"381","author":"DF Mackay","year":"2019","unstructured":"Mackay DF, Russell ER, Stewart K, MacLean JA, Pell JP, Stewart W (2019) Neurodegenerative disease mortality among former professional soccer players. New Engl J Med 381:1801\u201308","journal-title":"New Engl J Med"},{"issue":"3","key":"1045_CR14","first-page":"350","volume":"25","author":"AC Mckee","year":"2018","unstructured":"Mckee AC, Abdolmohammadi B, Stein TD (2018) The neuropathology of chronic traumatic encephalopathy. Handb Clin Neurol 25(3):350\u201364","journal-title":"Handb Clin Neurol"},{"key":"1045_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2398212818757098","volume":"2","author":"AS Mitchell","year":"2018","unstructured":"Mitchell AS, Czajkowski R, Zhang N, Jeffery K, Nelson AJD (2018) Retrosplenial cortex and its role in spatial cognition. Brain Neurosci Adv 2:1\u201313","journal-title":"Brain Neurosci Adv"},{"key":"1045_CR16","doi-asserted-by":"publisher","first-page":"07","DOI":"10.3389\/fnins.2019.00007","volume":"13","author":"M Mohamadpour","year":"2019","unstructured":"Mohamadpour M, Whitney K, Bergold PJ (2019) The importance of therapeutic time window in the treatment of traumatic brain injury. Front Neurosci 13:07","journal-title":"Front Neurosci"},{"key":"1045_CR17","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fnagi.2018.00292","volume":"10","author":"A Morin","year":"2018","unstructured":"Morin A, Mouzon B, Ferguson S, Paris D, Saltiel N, Lungmus C et al (2018) Treatment with nilvadipine mitigates inflammatory pathology and improves spatial memory in aged hTau mice after repetitive Mild TBI. Front Aging Neurosci 10:292","journal-title":"Front Aging Neurosci"},{"issue":"18","key":"1045_CR18","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1089\/neu.2012.2498","volume":"29","author":"B Mouzon","year":"2012","unstructured":"Mouzon B, Chaytow H, Crynen G, Bachmeier C, Stewart J, Mullan M et al (2012) Repetitive mild traumatic brain injury in a mouse model produces learning and memory deficits accompanied by histological changes. J Neurotrauma 29(18):2761\u201373","journal-title":"J Neurotrauma"},{"issue":"2","key":"1045_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ana.24064","volume":"75","author":"BC Mouzon","year":"2014","unstructured":"Mouzon BC, Bachmeier C, Ferro A, Ojo JO, Crynen G, Acker CM et al (2014) Chronic neuropathological and neurobehavioral changes in a repetitive mild traumatic brain injury model. Ann Neurol 75(2):241\u201354","journal-title":"Ann Neurol"},{"issue":"1","key":"1045_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/acn3.510","volume":"5","author":"BC Mouzon","year":"2018","unstructured":"Mouzon BC, Bachmeier C, Ojo JO, Acker CM, Ferguson S, Paris D et al (2018) Lifelong behavioral and neuropathological consequences of repetitive mild traumatic brain injury. Ann Clin Transl Neurol 5(1):64\u201380","journal-title":"Ann Clin Transl Neurol"},{"issue":"7","key":"1045_CR21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/jnen\/nlw035","volume":"75","author":"JO Ojo","year":"2016","unstructured":"Ojo JO, Mouzon B, Algamal M, Leary P, Lynch C, Abdullah L et al (2016) Chronic repetitive mild traumatic brain injury results in reduced cerebral blood flow, axonal injury, gliosis, and increased T-tau and tau oligomers. J Neuropathol Exp Neurol 75(7):636\u201355","journal-title":"J Neuropathol Exp Neurol"},{"key":"1045_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/NEN.0b013e3182814cdf","volume":"72","author":"JO Ojo","year":"2013","unstructured":"Ojo JO, Mouzon B, Greenberg MB, Bachmeier C, Mullan M, Crawford F (2013) Repetitive mild traumatic brain injury augments tau pathology and glial activation in aged hTau mice. J Neuropathol Exp Neurol 72:137\u2013151","journal-title":"J Neuropathol Exp Neurol"},{"key":"1045_CR23","doi-asserted-by":"publisher","first-page":"33927","DOI":"10.1074\/jbc.M114.608091","volume":"289","author":"D Paris","year":"2014","unstructured":"Paris D, Ait-Ghezala G, Bachmeier C, Laco G, Beaulieu-Abdelahad D, Lin Y et al (2014) The spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-$$ \\beta $$ production and Tau hyperphosphorylation. J Biol Chem 289:33927\u201333944","journal-title":"J Biol Chem"},{"issue":"3\u20134","key":"1045_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2119\/molmed.2010.00180","volume":"17","author":"D Paris","year":"2011","unstructured":"Paris D, Bachmeier C, Patel N, Quadros A, Volmar C-H, Laporte V et al (2011) Selective antihypertensive dihydropyridines lower A$$ \\beta $$ accumulation by targeting both the production and the clearance of A$$ \\beta $$ across the blood\u2013brain barrier. Mol Med 17(3\u20134):149\u201362","journal-title":"Mol Med"},{"issue":"1","key":"1045_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.brainres.2003.11.061","volume":"999","author":"D Paris","year":"2004","unstructured":"Paris D, Quadros A, Humphrey J, Patel N, Crescentini R, Crawford F et al (2004) Nilvadipine antagonizes both A$$ \\beta $$ vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice. Brain Res 999(1):53\u201361","journal-title":"Brain Res"},{"key":"1045_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/2040622315582353","volume":"6","author":"J Peters","year":"2015","unstructured":"Peters J, Booth A, Peters R (2015) Potential for specific dihydropyridine calcium channel blockers to have a positive impact on cognitive function in humans: A systematic review. Ther Adv Chronic Disease 6:160\u2013169","journal-title":"Ther Adv Chronic Disease"},{"issue":"1","key":"1045_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40478-017-0472-2","volume":"5","author":"JE Schweig","year":"2017","unstructured":"Schweig JE, Yao H, Beaulieu-Abdelahad D, Ait-Ghezala G, Mouzon B, Crawford F et al (2017) Alzheimer\u2019s disease pathological lesions activate the spleen tyrosine kinase. Acta Neuropathol Commun 5(1):69","journal-title":"Acta Neuropathol Commun"},{"key":"1045_CR28","doi-asserted-by":"publisher","first-page":"13378","DOI":"10.1074\/jbc.RA119.008033","volume":"294","author":"JE Schweig","year":"2019","unstructured":"Schweig JE, Yao H, Coppola K, Jin C, Crawford F, Mullan M et al (2019) Spleen tyrosine kinase (SYK) blocks autophagic Tau degradation in vitro and in vivo. J Biol Chem 294:13378\u201313395","journal-title":"J Biol Chem"},{"issue":"4","key":"1045_CR29","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2174\/18715273113126660196","volume":"13","author":"E Shohami","year":"2014","unstructured":"Shohami E, Biegon A (2014) Novel approach to the role of NMDA receptors in traumatic brain injury. CNS Neurol Disord Drug Targets 13(4):567\u201373","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"4","key":"1045_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nrneurol.2013.29","volume":"9","author":"DH Smith","year":"2013","unstructured":"Smith DH, Johnson VE, Stewart W (2013) Chronic neuropathologies of single and repetitive TBI: substrates of dementia? Nat Rev Neurol 9(4):211\u201321","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1045_CR31","doi-asserted-by":"publisher","first-page":"97.e7","DOI":"10.1016\/j.genhosppsych.2014.09.016","volume":"37","author":"A Tateno","year":"2015","unstructured":"Tateno A, Sakayori T, Takizawa Y, Yamamoto K, Minagawa K, Okubo Y (2015) A case of Alzheimer\u2019s disease following mild traumatic brain injury. Gen Hosp Psychiatry 37(1):97.e7\u201397.e9","journal-title":"Gen Hosp Psychiatry"},{"issue":"9","key":"1045_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6609a1","volume":"66","author":"CA Taylor","year":"2017","unstructured":"Taylor CA, Bell JM, Breiding MJ, Xu L (2017) Traumatic brain injury-related emergency department visits, hospitalizations, and deaths\u2014United States, 2007 and 2013. MMWR Surveill Summ 66(9):1\u201316","journal-title":"MMWR Surveill Summ"},{"issue":"4","key":"1045_CR33","doi-asserted-by":"publisher","first-page":"e0153608","DOI":"10.1371\/journal.pone.0153608","volume":"11","author":"R Tzekov","year":"2016","unstructured":"Tzekov R, Dawson C, Orlando M, Mouzon B, Reed J, Evans J et al (2016) Sub-Chronic neuropathological and biochemical changes in mouse visual system after repetitive mild traumatic brain injury. PLoS ONE 11(4):e0153608","journal-title":"PLoS ONE"},{"key":"1045_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/NEN.0000000000000059","volume":"73","author":"R Tzekov","year":"2014","unstructured":"Tzekov R, Quezada A, Gautier M, Biggins D, Frances C, Mouzon B et al (2014) Repetitive mild traumatic brain injury causes optic nerve and retinal damage in a mouse model. J Neuropathol Exp Neurol 73:345\u2013361","journal-title":"J Neuropathol Exp Neurol"},{"key":"1045_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.brainresbull.2013.09.011","volume":"99","author":"G-Z Xu","year":"2013","unstructured":"Xu G-Z, Wang M-D, Liu K-G, Bai Y-A, Wu W, Li W (2013) A meta-analysis of treating acute traumatic brain injury with calcium channel blockers. Brain Res Bull 99:41\u201347","journal-title":"Brain Res Bull"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-020-01045-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-020-01045-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-020-01045-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:43:48Z","timestamp":1634604228000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-020-01045-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1045"],"URL":"https:\/\/doi.org\/10.1186\/s40478-020-01045-x","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"9 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were carried out under Institutional Animal Care and Use Committee (IACUC) approval and in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}